FFCP PHASE1:Hg19::chr2:182322911..182322927,+
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p12@ITGA4 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_12_at_ITGA4_5end |
Coexpression cluster: | C1481_CD4_CD8_thymus_CD14CD16_CD14_granulocyte_CD19 |
Association with transcript: | -40bp_to_ENST00000478440_5end |
EntrezGene: | ITGA4 |
HGNC: | 6140 |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p12@ITGA4 |
---|
0
2
4
6
8
10
12
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
lymphoid lineage restricted progenitor cell | 2.92e-38 | 52 |
lymphocyte | 2.47e-37 | 53 |
common lymphoid progenitor | 2.47e-37 | 53 |
hematopoietic stem cell | 2.13e-35 | 168 |
hematopoietic cell | 1.12e-32 | 177 |
hematopoietic oligopotent progenitor cell | 5.97e-32 | 161 |
hematopoietic multipotent progenitor cell | 5.97e-32 | 161 |
nongranular leukocyte | 3.00e-28 | 115 |
leukocyte | 9.59e-26 | 136 |
mature alpha-beta T cell | 5.62e-24 | 18 |
Showing 1 to 10 of 26 entries
Ontology term | p-value | n |
---|---|---|
blood | 2.21e-11 | 15 |
haemolymphatic fluid | 2.21e-11 | 15 |
organism substance | 2.21e-11 | 15 |
hemopoietic organ | 2.64e-10 | 7 |
immune organ | 2.64e-10 | 7 |
hematopoietic system | 3.78e-09 | 98 |
blood island | 3.78e-09 | 98 |
connective tissue | 3.07e-08 | 371 |
hemolymphoid system | 1.17e-07 | 108 |
Showing 1 to 9 of 9 entries
Ontology term | p-value | n |
---|---|---|
leukemia | 2.50e-12 | 39 |
hematologic cancer | 4.25e-12 | 51 |
immune system cancer | 4.25e-12 | 51 |
myeloid leukemia | 1.47e-09 | 31 |
Showing 1 to 4 of 4 entries